Jun 16, 2020
International Study of More Than 8,000 People Showed Ertugliflozin Does Not Increase Risk of Cardiac Events
Jun 16, 2020
$3.27 Billion Retinal Surgery Devices Market Assessment 2020-2026 - COVID-19 Updated
Jun 15, 2020
Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
Jun 15, 2020
Data Presented at the 2020 ADA Scientific Sessions Show that Patients Treated with Cirius Therapeutics' MSDC-0602K Showed Improved Insulin Handling
Jun 15, 2020
Dompé Presents Phase II Clinical Trial Results for Ladarixin in New-Onset Type 1 Diabetes at the American Diabetes Association's Scientific Sessions
Jun 15, 2020
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
Jun 15, 2020
Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product
Jun 15, 2020
DarioHealth Presents New Studies Demonstrating Sustained Improvements in Blood Glucose and Blood Pressure Control in Users with Diabetes and Hypertension at the American Diabetes Association's 80th Scientific Sessions
Jun 15, 2020
Global Thymus Cancer Market Insights by Cancer Type, Treatment, End-user and Region (2017-2025)
Jun 15, 2020
Dapagliflozin May Help Reduce Onset of Type 2 Diabetes
Jun 15, 2020
June HHT Global Awareness Month Highlights COVID-19 Risk for Those With Rare Genetic Disease: As Many AS 90% Unaware They Have HHT
Jun 15, 2020
Provention Bio's Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
Jun 15, 2020
Contego Medical Announces the Start of Enrollment in the PERFORMANCE II Carotid Stenting Clinical Trial
Jun 14, 2020
Study Finds Minority Patients in States with Medicaid Expansion Experience Fewer Leg Amputations
Jun 13, 2020
Study Finds Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in People with Type 1 and Type 2 Diabetes
Jun 13, 2020
Once-weekly Trulicity® (dulaglutide) demonstrates significantly higher adherence and more persistence compared to once-weekly semaglutide and exenatide injections
Jun 12, 2020
EHA25Virtual: A Safe and Strikingly Effective Biologic Therapy for the World's Second Most Common Hereditary Bleeding Disorder
Jun 12, 2020
EHA25Virtual: Pegcetacoplan, a Novel C3 Complement Inhibitor - Beginning of a New Era in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jun 12, 2020
RSD/CRPS Book by Dr. Katinka van der Merwe Helps Patients Understand the Severe Pain and Symptoms
Jun 12, 2020
QBioMed to Support and Exhibit at Living Beyond Breast Cancer 2020 Virtual Conference on June 13-14, 2020